Elicio Therapeutics 주식 (NASDAQ: ELTX)

에 대한 최신 뉴스 Elicio Therapeutics (NASDAQ:ELTX) 주식

Elicio Therapeutics

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALVO

BBGI

BCAX

ELTX

FOXO

ISPC

JBHT

LYTS

MDXG

NATR

NUKK

OFIX

TMCI

TXNM

VIAV

WILC

버서스 시스템즈(NASDAQ:VS)의 주가는 회사가 국제적인 입지를 성장시키기 위한 전략의 일환으로 회사가 브라질 시장으로의 확장을 발표한 후 급등했다. 버서스 시스템즈의 주가가 금요일 프리마켓 거래에서 71.2% 상승하여 $3.39에 거래되었다.

버서스 시스템즈 주식이 약 71% 상승한 이유: 프리마켓에서 움직이는 20개의 주식

Elicio Therapeutics Inc

Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) has outperformed the market over the past 15 years by 11.29% on an annualized basis producing an average annual return of 23.25%. Currently, Lam Research has a market capitalization of $103.26 billion. 
Buying $1000 In LRCX: If an investor had bought $1000 of LRCX stock 15 years ago, it would be worth $23,417.91 today based on a price of $80.25 for LRCX at the time of writing.
<h3>Lam Research's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737157509_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LRCX

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

Meta CEO Mark Zuckerberg, 40, recently appeared on The Joe Rogan Experience, casually wearing a $900,000 F.P. Journe FFC watch mere weeks after being spotted with a $1.2 million Patek Philippe Grand Complications in an Instagram video.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Mark Zuckerberg spotted wearing a rare FP Journe FFC in platinum. &#x231a;&#xFE0F; This limited-edition timepiece, created in collaboration with Francis Ford Coppola, features an innovative hour display. Photo: joerogan // fpjourneofficial<a href="https://twitter.com/hashtag/Zuckerberg?src=hash&amp;ref_src=twsrc%5Etfw">#Zuckerberg</a> <a href="https://twitter.com/hashtag/FPJourne?src=hash&amp;ref_src=twsrc%5Etfw">#FPJourne</a> <a href="https://twitter.com/hashtag/LuxuryWatches?src=hash&amp;ref_src=twsrc%5Etfw">#LuxuryWatches</a> <a href="https://t.co/3m5pgMnoXG">pic.twitter.com/3m5pgMnoXG</a>
&mdash; SIMONSAYSDRIP (@simonsaysdrip) <a href="https://twitter.com/simonsaysdrip/status/1878023663611425092?ref_src=twsrc%5Etfw">January 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
</ul>
The F.P. Journe FFC watch is a masterpiece of engineering and storytelling. Its unique design features a titanium hand in an armored glove, displaying the hours through intricate finger movements – a concept inspired by 16th-century prosthetics.&nbsp;
This idea came from a conversation in 2012 between Coppola and the watchmaker François-Paul Journe. Coppola asked if a watch could tell time using the old finger-counting method. From there, the watchmaker created this amazing piece with a titanium hand shaped like an armored glove moving its fingers to show the time.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x2728; F.P Journe FFC &#x2728; ( incroyable &#x1f929; )<a href="https://t.co/H6WDu4gREz">https://t.co/H6WDu4gREz</a> <a href="https://t.co/DASkNcUkfj">pic.twitter.com/DASkNcUkfj</a>
&mdash; Xcellent Watches&#xAE; (@XcellentWatches) <a href="https://twitter.com/XcellentWatches/status/1647203128180195328?ref_src=twsrc%5Etfw">April 15, 2023</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a>
This horological marvel is powered by a complex system of cams and bridges that animate the armored hand to indicate the time. The prototype of this watch sold for a staggering CHF 4.5 million at a 2021 charity auction, further solidifying its status as a collector's dream. Like the one Zuckerberg wore, the production version is limited to only 15 watches made each year, making them super rare and highly sought after.
<h2 class="wp-block-heading">Zuckerberg's Watch Collection Expands</h2>
This F.P. Journe FFC isn't Zuckerberg's first venture into the world of luxury watches. In fact, the F.P. Journe FFC is just one of the many luxury watches Zuckerberg owns. Recently, he's been seen with a <a href="https://www.benzinga.com/news/24/12/42689559/mark-zuckerberg-talks-non-profit-achievements-while-displaying-a-1-2-million-patek-philippe-watch">$1.2 million Patek Philippe Grand Complications</a>, a <a href="https://www.benzinga.com/news/24/09/40969847/mark-zuckerberg-flaunts-watches-valued-at-a-cybertrucks-price">$141,000 Patek Philippe 5236P and a $100,000 De Bethune DB 25 Starry Varius</a>.&nbsp;
For someone who often wears plain T-shirts, hoodies and jeans, these fancy watches show a whole new side of him. This shift in style is part of Zuckerberg's effort to change how people see him.
Trending: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
<h2 class="wp-block-heading">A Lifestyle Upgrade</h2>
Zuckerberg's personal transformation has been hard to miss in the past year. He's traded his casual wardrobe for tailored designer suits, accessorized with gold chains and adopted longer, styled hair – a look that media outlets have dubbed "Mark Zuckerberg 3.0." This elevated style is part of a broader lifestyle overhaul that aligns with his evolving public persona.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Now do Mark Zuckerberg. He has a $300 million, 387-foot yacht named M/Y LAUNCHPAD built by Feadship and a $30 million support vessel named M/Y WINGMAN built by Damen. Two yachts, not just one. <a href="https://t.co/DQzapa11NL">pic.twitter.com/DQzapa11NL</a>
&mdash; rdub67 (@rdub067) <a href="https://twitter.com/rdub067/status/1865157729209184462?ref_src=twsrc%5Etfw">December 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Zuckerberg's taste for the finer things extends far beyond watches. For his 40th birthday, the Meta CEO reportedly spent $450 million on luxury acquisitions. These include a $300 million superyacht named Launchpad, a $30 million support vessel called Wingman and an $80 million Gulfstream G700 private jet.&nbsp;
Trending: With 100+ historic trademarks including some of the high grossing characters in history, like Cinderella, Snow White and Peter Pan, <a href="https://www.benzinga.com/money/elf-labs-1">this company is transforming the $2 trillion entertainment market with patented AR, VR, and AI tech. — For a short window, investors are able to claim $2/share ($980 min).</a>
His superyacht, Launchpad, is a 387-foot marvel designed by Espen Øino International and built by Feadship. It boasts state-of-the-art amenities like a swimming pool, helipad, cinema and a crew of 50 to cater to up to 26 guests. Meanwhile, Wingman enhances his maritime adventures with features like a diving center and submarine storage.&nbsp;
His Gulfstream G700 jet – a flagship of luxury aviation – offers customizable interiors and advanced technology, cementing Zuckerberg's reputation as a man who spares no expense for comfort and style.
Read Next:
<ul>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>

Mark Zuckerberg Wears Another Ultra-Rare $900,000 Watch, Designed With Francis Ford Coppola, During Joe Rogan Interview

Commercial Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMC#NYSE">CMC</a>) has outperformed the market over the past 10 years by 2.72% on an annualized basis producing an average annual return of 13.96%. Currently, Commercial Metals has a market capitalization of $5.75 billion. 
Buying $100 In CMC: If an investor had bought $100 of CMC stock 10 years ago, it would be worth $387.44 today based on a price of $50.60 for CMC at the time of writing.
<h3>Commercial Metals's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737156609_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Commercial Metals 10 Years Ago Would Be Worth Today

Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) has outperformed the market over the past 15 years by 7.57% on an annualized basis producing an average annual return of 19.53%. Currently, Alphabet has a market capitalization of $2.40 trillion. 
Buying $1000 In GOOGL: If an investor had bought $1000 of GOOGL stock 15 years ago, it would be worth $14,265.60 today based on a price of $195.86 for GOOGL at the time of writing.
<h3>Alphabet's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737155709_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GOOGL

Here's How Much You Would Have Made Owning Alphabet Stock In The Last 15 Years

Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) has outperformed the market over the past 5 years by 37.92% on an annualized basis producing an average annual return of 50.45%. Currently, Broadcom has a market capitalization of $1.11 trillion. 
Buying $1000 In AVGO: If an investor had bought $1000 of AVGO stock 5 years ago, it would be worth $7,707.34 today based on a price of $237.44 for AVGO at the time of writing.
<h3>Broadcom's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737154808_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AVGO

$1000 Invested In Broadcom 5 Years Ago Would Be Worth This Much Today

<a href="https://www.benzinga.com/news/25/01/42947081/a-salary-is-the-drug-they-give-you-to-forget-your-dreams-says-kevin-oleary-encourages-people-to-embrace-the-fear-of-failure">Kevin O'Leary</a>, the investor famously known from Shark Tank, has once again stepped into the heated debate about TikTok's future in the United States. Alongside billionaire entrepreneur Frank McCourt, O'Leary is pushing a bold plan to save the platform from a potential nationwide ban, which he says would be devastating for small businesses nationwide.
<h2 class="wp-block-heading">Why TikTok Matters to Small Businesses</h2>
TikTok is a key tool for the success of many small businesses in America. Kevin O'Leary says six million businesses use the app to sell products, find customers and make money. If TikTok is shut down, it would cause big problems for these businesses.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
</ul>
"I don&#8217;t want it shut down. It&#8217;s not good for my businesses, it&#8217;s not good for six million other small businesses in America that make a living off it," O'Leary said in a recent <a href="https://www.youtube.com/watch?v=9s94nz8JY-U">interview</a>. "We just need to take out the onerous piece – the spyware – that&#8217;s what Congress is upset about."
<h2 class="wp-block-heading">The Spyware Problem</h2>
TikTok&#8217;s controversy stems from its parent company, <a href="https://www.benzinga.com/tech/24/11/42069805/bytedance-valuation-soars-to-300b-despite-threat-of-us-tiktok-ban">ByteDance, a Chinese tech giant</a>. U.S. lawmakers from both parties have raised concerns about the app's data security and potential ties to the Chinese government. The fear is that TikTok's algorithm could serve as a tool for surveillance or propaganda.
O'Leary and McCourt's solution? Buy TikTok's U.S. operations outright. <a href="https://www.benzinga.com/general/entertainment/25/01/42834240/kevin-oleary-joins-the-peoples-bid-for-tiktok-as-pending-ban-looms">Their proposal</a> involves acquiring the app without its famous algorithm – the technology that powers TikTok's addictive "For You" feed. "We don&#8217;t want to buy the algorithm, we can&#8217;t use it. That&#8217;s spyware," O'Leary explained. "We&#8217;re going to rebuild the product and make it much better."
See Also: With 100+ historic trademark victories, this company holds IP for some of the highest-grossing characters in history. Now, they've propelled these icons into the future using next-gen patented AR, VR, and AI technology. <a href="https://www.benzinga.com/money/elf-labs-1">There&#8217;s now a limited window for investors to claim shares at just $2/share with $980 minimum—but the clock is ticking.</a>
<h2 class="wp-block-heading">A Race Against Time</h2>
The urgency behind O'Leary's bid is tied to a looming deadline. A law passed earlier this year could result in TikTok being banned in the United States starting Jan. 19, 2025, unless the app is sold. <a href="https://www.benzinga.com/general/social-media/24/12/42680367/tiktok-on-trial-supreme-court-prepares-to-weigh-national-security-risks">The Supreme Court is deciding</a> whether this law will go into effect and O'Leary and McCourt are pushing to get their offer accepted before it's too late.
Critics have questioned whether TikTok can remain popular without its algorithm, which is central to its success. The algorithm is the magic behind the content recommendations that keep users hooked. But O'Leary insists that the platform's success doesn't hinge on the existing technology.
Trending: Built on the trusted network of Fortune 500 companies, <a href="https://www.benzinga.com/money/web3-enabler-the-most-boring-blockchain-company-partners-with-salesforce">this blockchain company partners with Salesforce to uproot lengthy and expensive B2B transactions, and you can invest with just $100.</a>
O'Leary and McCourt's group, called The People's Bid for TikTok, has support from investors and tech experts, including Tim Berners-Lee, the inventor of the World Wide Web. They've also talked to lawmakers and plan to work with President-elect Donald Trump to close the deal.
McCourt emphasized the importance of keeping TikTok running for its millions of users. "By keeping the platform alive without relying on the current TikTok algorithm and avoiding a ban, millions of Americans can continue to enjoy the platform," he said. "We look forward to working with ByteDance, President-elect Trump and the incoming administration to get this deal done."
Even though ByteDance has repeatedly stated that <a href="https://www.benzinga.com/general/social-media/25/01/42994923/mrbeast-discussing-buying-tiktok-with-billionaires-to-prevent-us-shutdown-lets-see-if-we-can-pull-this-off">TikTok is not for sale</a>, O&#8217;Leary and McCourt are committed to finding a solution.
Read Next:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>According to Juniper Research, the total value of B2B cross-border payments stored on the blockchain is projected to exceed $4.4 trillion — <a href="https://www.benzinga.com/money/web3-enabler-future-of-enterprise-transactions">Join the first company to bring blockchain payments to Salesforce early with just $100.</a></li>
</ul>

Kevin O'Leary Warns That Shutting Down TikTok Would Hurt '6 Million Small Businesses In America' That Rely On It To Make A Living

Live Nation Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>) has outperformed the market over the past 10 years by 7.04% on an annualized basis producing an average annual return of 18.27%. Currently, Live Nation Entertainment has a market capitalization of $31.27 billion. 
Buying $100 In LYV: If an investor had bought $100 of LYV stock 10 years ago, it would be worth $547.26 today based on a price of $135.61 for LYV at the time of writing.
<h3>Live Nation Entertainment's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737153016_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Live Nation Entertainment 10 Years Ago Would Be Worth Today

Offerings

MOBX

Mobix Labs Files For Mixed Shelf Offering Of Up To $75M

Management

OKLO

Oklo's Christopher Wright Notified He Intended To Resign As A Director Upon His Confirmation As United States Secretary Of Energy

KULR

KULR Technology Group Files For Mixed Shelf Offering; Size Not Disclosed

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

Mawson Infrastructure Group Appoints William C. Regan As Chief Financial Officer

On January&nbsp;13, 2025, Omega Therapeutics, Inc. (the "Company") received a notice of default (the "Notice of Default") under the Loan and Security Agreement, dated as of March&nbsp;9, 2018 (the "Loan Agreement"), by and between the Company and Banc of California ("BOC"), from BOC.
The Notice of Default specified that, in BOC's view, one or more events of default had occurred based on alleged material adverse changes in the Company's cash runway, financing opportunities, solvency, pre-clinical programs, stock price and corporate governance, pursuant to Sections 6.2, 8.3 and 8.5 of the Loan Agreement.
Based on its assertion of the alleged events of default, BOC declared all outstanding obligations under the Loan Agreement immediately due and payable purportedly in accordance with Section&nbsp;9.1(g) of the Loan Agreement. BOC also set off and applied to the balance of the Company's obligations under the Loan Agreement $14,666,666.72 of deposits of the Company held by BOC.
The Company has responded by letter to the Notice of Default, advising BOC that no events of default under the Loan Agreement have occurred or are continuing. Prior to receiving the Notice of Default, the Company had maintained the required minimum cash balances, and has timely paid BOC its indebtedness and other obligations as they become due. In addition, the bases for an event of default asserted in the Notice of Default, including with respect to the Company's stock price and corporate governance, do not align with the covenants in the Loan Agreement. The Company believes it is not in default under the Loan Agreement, and that BOC did not have the right to accelerate the indebtedness or otherwise pursue remedies thereunder, and has attempted to resolve this matter with BOC consensually, while reserving all of its rights to legal or regulatory action.

Financing

Legal

OMGA

Omega Therapeutics Receives Default Notice From Banc Of California; Disputes Alleged Breach Of Loan Terms, Bank Sets Off $14.67M Deposits; Maintains Compliance Claims, Seeks Resolution

Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) has outperformed the market over the past 10 years by 11.71% on an annualized basis producing an average annual return of 22.95%. Currently, Meta Platforms has a market capitalization of $1.55 trillion. 
Buying $100 In META: If an investor had bought $100 of META stock 10 years ago, it would be worth $798.50 today based on a price of $612.36 for META at the time of writing.
<h3>Meta Platforms's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737152107_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Meta Platforms 10 Years Ago Would Be Worth Today

On January 17, 2025, Tetra Tech EC, Inc. ("TtEC"), a wholly owned subsidiary of Tetra Tech, Inc. (the "Company"), entered into a settlement agreement with the United States of America, acting through the Civil Division of the United States Attorney's Office of the United States Department of Justice and on behalf of the Department of the Navy (collectively, the "United States"), and also filed a proposed consent decree with the United States District Court for the Northern District of California (the "Court"), to resolve the previously disclosed civil litigation related to TtEC's performance of environmental remediation services at the former Hunters Point Naval Shipyard in San Francisco, California (the "Covered Conduct").
&nbsp;
Under the terms of the settlement agreement and consent decree, TtEC has agreed to pay to the United States $57 million and $40 million for False Claims Act ("FCA") claims and Comprehensive Environmental Response, Compensation and Liability Act ("CERCLA") claims, respectively (the "Settlement Amounts"), which the Company expects to pay with cash on hand and by drawing on its credit facility. Upon entry of the Consent Decree by the Court and the United States' receipt of the settlement amounts, the United States will release TtEC from any and all civil or administrative monetary claims for the Covered Conduct under the civil FCA, the CERCLA, and other specified civil statutes and common law theories of liability.
&nbsp;
The consent decree is subject to a number of contingencies that could prevent it from being finalized with its current terms. In particular, and without limitation, (i) the consent decree is required to be lodged with the Court for a period of 30 days for public notice and comment, and the United States has reserved the right to withdraw or withhold its consent if the comments regarding the consent decree disclose facts or considerations that indicate the consent decree is inappropriate, improper or inadequate; and (ii) the Court might determine not to enter the consent decree as currently written or as approved by the United States. There can be no assurance that the contingencies will not preclude entry of the consent decree.
&nbsp;
TtEC entered into the settlement agreement and consent decree to avoid the delay, uncertainty and expense of protracted litigation. The settlement agreement and consent decree contain no admission of liability by TtEC. In addition, the settlement agreement and consent decree do not resolve the previously disclosed ancillary claims brought by third-party private plaintiffs from the same services provided by TtEC at Hunters Point.
&nbsp;
TtEC has initiated litigation with the insurance carrier with which TtEC maintained liability policies regarding the reasonably possible payment or reimbursement of a significant portion of the Settlement Amounts. TtEC can give no assurances as to what portion, if any, of the Settlement Amounts will be recovered from the insurance carrier.

TTEK

Tetra Tech Subsidiary Settles Litigation for Hunters Point Remediation with U.S. For $97M; $57M For False Claims Act, $40M For Comprehensive Environmental Response, Compensation and Liability Act; Consent Decree Pending Public Comment And Court Approval; Settlement Agreement Involves No Admission Of Liability, Third-Party Claims Still Unresolved; Insurance Recovery Uncertain

With Donald Trump&#8216;s swearing-in as the 47th president rapidly approaching, betting markets are in overdrive, pricing in a flurry of executive actions.
Traders on the CFTC-regulated platform Kalshi see an 80% chance Trump will sign at least 15 executive orders on his first day, with the most aggressive wagers banking on 50 or more — offering a 28% implied probability.
From a potential flood of executive orders to new tariffs, immigration crackdowns, and even Bitcoin policy shifts, the first days of the Trump administration could be some of the most consequential in recent history.
<h1 class="wp-block-heading">How Many Executive Orders On Trump Day 1?</h1>
The Kalshi platform, which allows traders to bet on political and economic outcomes, indicates Trump will sign an average of 38 executive orders on Inauguration Day.
<iframe loading="lazy" style="border: 0;" src="https://kalshi.com/external-widgets/events/KXEOCOUNTDAY1B-25JAN20?color_scheme=light&amp;widget_size=medium&amp;variant=a&amp;ids=KXEOCOUNTDAY1B-25JAN20-49&amp;ids=KXEOCOUNTDAY1B-25JAN20-22.0&amp;ids=KXEOCOUNTDAY1B-25JAN20-27.0" width="488px" height="196px"></iframe>

For comparison, President Joe Biden issued 17 orders on his first day in 2021, while Trump signed 14 in 2017 during his first term. The most aggressive bet — on 50 or more orders — carries a 28% probability by Friday 3:10 p.m. ET, meaning a $1 wager could return $3 if Trump surpasses that threshold.
<h1 class="wp-block-heading">Will Trump Lower Corporate And High-Earner Taxes?</h1>
Betting markets assign a 55% probability that Trump will cut corporate taxes this year, signaling a potential reversal of Biden-era policies. 
Meanwhile, there&#8217;s an 89% chance that he will extend tax cuts for high earners, a key priority for his administration. Trump&#8217;s 2017 tax reform significantly reduced corporate tax rates from 35% to 21%. 
<h1 class="wp-block-heading">Immigration Crackdown: A Near Certainty</h1>
One of the most heavily priced-in actions is Trump&#8217;s potential move on illegal immigration. 
Betting markets assign a 94% probability that he will take action on deportations within his first 100 days. 
This aligns with his campaign rhetoric, where he vowed to reinstate and expand the &#8220;Remain in Mexico&#8221; policy, increase deportations, and impose tougher border controls.
<h1 class="wp-block-heading">Tariffs: Who's In The Crosshairs?</h1>
Markets are also weighing in on which countries Trump may hit with tariffs in his first 48 hours.
<ul>
<li>China: 46% chance of new tariffs</li>
<li>Mexico: 46% chance</li>
<li>Canada: 35% chance</li>
<li>European Union: 10% chance</li>
</ul>
<iframe loading="lazy" src="https://kalshi.com/external-widget/events-categorical/KXTARIFFSC-25JAN23?color_scheme=light&#038;widget_size=large" width="488px" height="242px" style="border:0" /></iframe>

Trump has already promised to slap a 10% universal tariff on all imports and potentially much steeper duties on Chinese goods.
<h1 class="wp-block-heading">Declaring A National Emergency: 80% Probability</h1>
Another major bet is whether Trump will declare a national emergency within his first 100 days — a scenario with an 80% probability.
While the specific trigger remains unclear, possibilities include immigration, trade or domestic unrest.
His 2019 national emergency declaration to fund the border wall set a precedent, making this a key market-moving event to watch.
<h1 class="wp-block-heading">Bitcoin Reserve: A Surprising 66% Chance</h1>
A more unconventional wager is whether Trump will establish a National Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) Reserve this year, a market with a 66% implied probability.
While Trump was previously skeptical of cryptocurrencies, he recently shifted his stance, touting himself as a crypto-friendly candidate. 
If he moves forward with such a reserve, it could mark a seismic shift in U.S. financial policy.
<iframe loading="lazy" style="border: 0;" src="https://kalshi.com/external-widgets/events/KXBTCRESERVE-26?color_scheme=light&amp;widget_size=medium&amp;variant=a" width="488px" height="160px"></iframe>
<h1 class="wp-block-heading">Birthright Citizenship: A 69% Likelihood of Action</h1>
Markets are also pricing in a 69% chance that Trump will attempt to end birthright citizenship within his first 100 days. 
This would likely face immediate legal challenges as the 14th Amendment guarantees citizenship to anyone born in the U.S. Nonetheless, it remains a high-priority issue for his administration and traders are betting on early executive action.
Read Now:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43064144/wall-street-roars-ahead-of-trumps-inauguration-intel-rallies-bitcoin-tops-105000-whats-driving-markets-friday">Wall Street Roars Ahead Of Trump&#8217;s Inauguration, Intel Rallies, Bitcoin Tops $105,000: What&#8217;s Driving Markets Friday?</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Government

Regulations

Econ #s

$BTC

Betting Markets Brace For Wave Of Executive Orders On Trump Day 1: Immigration, Tariffs Top Issues On The Table

NVDA

NVIDIA Says Implementation Of Additional Due Diligence Measures For Advanced Computing IC Rule Not Expected To Impact Ops/Sales To China; Co Is An Approved IC Designer

Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) has been analyzed by 19 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">8</td>
<td align="right">8</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $258.32, a high estimate of $310.00, and a low estimate of $210.00. Surpassing the previous average price target of $221.83, the current average has increased by 16.45%.
<img src="https://www.benzinga.com/files/images/story/2025/1737151256_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Royal Caribbean Gr. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$295.00</td>
<td>$253.00</td>
</tr>
<tr>
<td>Jamie Rollo</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$210.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Brandt Montour</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$287.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>James Hardiman</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$283.00</td>
<td>$257.00</td>
</tr>
<tr>
<td>Lizzie Dove</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$275.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>Steven Wieczynski</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$310.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Patrick Scholes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$272.00</td>
<td>$204.00</td>
</tr>
<tr>
<td>Richard Clarke</td>
<td>Bernstein</td>
<td>Announces</td>
<td>Outperform</td>
<td>$290.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrew Didora</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$240.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Ivan Feinseth</td>
<td>Tigress Financial</td>
<td>Raises</td>
<td>Buy</td>
<td>$270.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Paul Golding</td>
<td>Macquarie</td>
<td>Raises</td>
<td>Outperform</td>
<td>$250.00</td>
<td>$189.00</td>
</tr>
<tr>
<td>Daniel Politzer</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$232.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>James Hardiman</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$257.00</td>
<td>$253.00</td>
</tr>
<tr>
<td>Brandt Montour</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$245.00</td>
<td>$244.00</td>
</tr>
<tr>
<td>Lizzie Dove</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$245.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Andrew Didora</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$210.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Steven Wieczynski</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$250.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$243.00</td>
<td>$213.00</td>
</tr>
<tr>
<td>Brandt Montour</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$244.00</td>
<td>$195.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Royal Caribbean Gr. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Royal Caribbean Gr compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Royal Caribbean Gr's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/RCL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Royal Caribbean Gr analyst ratings.</a>
<h2>Get to Know Royal Caribbean Gr Better</h2>
Royal Caribbean is the world's second-largest cruise company, operating 68 ships across five global and partner brands in the cruise vacation industry. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises. The selection of brands in the portfolio allows Royal to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in 2021.
<h3>Royal Caribbean Gr: A Financial Overview</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Positive Revenue Trend: Examining Royal Caribbean Gr's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 17.45% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Royal Caribbean Gr's net margin excels beyond industry benchmarks, reaching 22.74%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Royal Caribbean Gr's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 17.02%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Royal Caribbean Gr's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.0% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 3.06, caution is advised due to increased financial risk.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Analyst Expectations For Royal Caribbean Gr's Future

During the last three months, 4 analysts shared their evaluations of Reynolds Consumer Prods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REYN#NASDAQ">REYN</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $28.0, a high estimate of $29.00, and a low estimate of $27.00. A 4.27% drop is evident in the current average compared to the previous average price target of $29.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1737151249_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Reynolds Consumer Prods among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$27.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$29.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$28.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$28.00</td>
<td>$29.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Reynolds Consumer Prods. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Reynolds Consumer Prods compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Reynolds Consumer Prods's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Reynolds Consumer Prods's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/REYN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Reynolds Consumer Prods analyst ratings.</a>
<h2>All You Need to Know About Reynolds Consumer Prods</h2>
Reynolds Consumer Products Inc is a provider of household products. The firm is engaged in the production and sales of cooking products, waste and storage products, and tableware. It operates through four reportable segments namely, Reynolds Cooking and Baking, Hefty Waste and Storage, Hefty Tableware, and Presto Products. Reynolds Cooking and Baking segment produce branded and store brand aluminum foil, disposable aluminum pans, parchment paper, freezer paper, wax paper, butcher paper, plastic wrap, baking cups, oven bags and slow cooker liners.
<h3>Breaking Down Reynolds Consumer Prods's Financial Performance</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Decline in Revenue: Over the 3 months period, Reynolds Consumer Prods faced challenges, resulting in a decline of approximately -2.67% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Reynolds Consumer Prods's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 9.45%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Reynolds Consumer Prods's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 4.19%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Reynolds Consumer Prods's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.77%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.88.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

REYN

Demystifying Reynolds Consumer Prods: Insights From 4 Analyst Reviews

During the last three months, 5 analysts shared their evaluations of Bank OZK (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OZK#NASDAQ">OZK</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Bank OZK, presenting an average target of $48.2, a high estimate of $53.00, and a low estimate of $40.00. This current average has increased by 3.88% from the previous average price target of $46.40. 
<img src="https://www.benzinga.com/files/images/story/2025/1737151237_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A clear picture of Bank OZK's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matt Olney</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$53.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Nicholas Holowko</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$51.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Jared Shaw</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$40.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$46.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Matt Olney</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$51.00</td>
<td>$48.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Bank OZK. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Bank OZK compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Bank OZK's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Bank OZK's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/OZK/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Bank OZK analyst ratings.</a>
<h2>Get to Know Bank OZK Better</h2>
Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit and individual retirement accounts to loan services like real estate, consumer, commercial and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking and other related services.
<h3>Bank OZK: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Bank OZK's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 7.64%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Bank OZK's net margin is impressive, surpassing industry averages. With a net margin of 41.88%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Bank OZK's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.43% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Bank OZK's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.48% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Bank OZK's debt-to-equity ratio is below the industry average. With a ratio of 0.12, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 5 Analyst Projections For Bank OZK

In the preceding three months, 4 analysts have released ratings for Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>), presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $233.75, along with a high estimate of $255.00 and a low estimate of $215.00. This upward trend is apparent, with the current average reflecting a 6.25% increase from the previous average price target of $220.00.
<img src="https://www.benzinga.com/files/images/story/2025/1737151226_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A comprehensive examination of how financial experts perceive Taiwan Semiconductor is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Simon Coles</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$255.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$225.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Simon Coles</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$240.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Simon Coles</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$215.00</td>
<td>$200.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Taiwan Semiconductor. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Taiwan Semiconductor compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Taiwan Semiconductor's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Taiwan Semiconductor's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/TSM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Taiwan Semiconductor analyst ratings.</a>
<h2>Unveiling the Story Behind Taiwan Semiconductor</h2>
Taiwan Semiconductor Manufacturing Co. is the world's largest dedicated chip foundry, with over 60% market share. TSMC was founded in 1987 as a joint venture of Philips, the government of Taiwan, and private investors. It went public as an ADR in the us in 1997. TSMC's scale and high-quality technology allow the firm to generate solid operating margins, even in the highly competitive foundry business. Furthermore, the shift to the fabless business model has created tailwinds for TSMC. The foundry leader has an illustrious customer base, including Apple, AMD, and Nvidia, that looks to apply cutting-edge process technologies to its semiconductor designs. TSMC employs more than 73,000 people.
<h3>Taiwan Semiconductor's Financial Performance</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Over the 3 months period, Taiwan Semiconductor showcased positive performance, achieving a revenue growth rate of 38.95% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 42.81%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Taiwan Semiconductor's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 8.36% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Taiwan Semiconductor's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.35% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Taiwan Semiconductor's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.01.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 4 Analyst Projections For Taiwan Semiconductor

An announcement from Elicio Therapeutics ( ($ELTX) ) is now available. Elicio Therapeutics has appointed Robert Connelly as its Principal Accountin...

Elicio Therapeutics Appoints Robert Connelly as Financial Officer

JonesResearch analyst Soumit Roy initiated coverage of Elicio Therapeutics (ELTX) with a Buy rating and $9 price target Elicio's off-the-shelf canc...

Elicio Therapeutics initiated with a Buy at JonesResearch

Elicio Therapeutics (ELTX) presented updated preliminary results from the ongoing AMPLIFY-7P Phase 1 clinical trial of ELI-002, an Amphiphile cance...

Elicio Therapeutics presents updated preliminary results from AMPLIFY-7P

JonesTrading analyst Soumit Roy maintained a Buy rating on Elicio Therapeutics (ELTX – Research Report) today. The company's shares opened today at...

Elicio Therapeutics (ELTX) Receives a Buy from JonesTrading

Elicio Therapeutics GAAP EPS of -$1.39

Elicio Therapeutics (ELTX) announced the completion of enrollment in the Phase 2 AMPLIFY-7P study. The randomized Phase 2 study is evaluating a 7-p...

Elicio Therapeutics announces completion of Phase 2 AMPLIFY-7P study enrollment

Elicio Therapeutics ( ($ELTX) ) has issued an announcement. Elicio Therapeutics has announced updated results from its ELI-002 Phase 1 AMPLIFY-201 ...

Elicio Therapeutics Advances ELI-002 and Secures Funding

Elicio Therapeutics (ELTX) presented updated results from the Phase 1 AMPLIFY-201 clinical trial of ELI-002, an Amphiphile, AMP, cancer vaccine tha...

Elicio Therapeutics presents updated results from ELI-002 Phase 1 study

In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Elicio Therapeutics (ELTX – Research Report). The company's sha...

JonesTrading Sticks to Their Buy Rating for Elicio Therapeutics (ELTX)

Screenshot 2024-06-07 at 5.22.00 PM

Biotech

General

Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors

Screenshot 2024-04-10 at 5.39.01 PM

Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry

Screenshot 2024-04-04 at 5.26.54 PM

Unlocking The Power Of Immunotherapy: Elicio Therapeutics&#39; (NASDAQ: ELTX) Novel AMP Platform

Earnings

Press Releases

Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines

Elicio Therapeutics Reports Inducement Grants

Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit

Health Care

Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer ("SITC") 2024 Annual Meeting

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024

Abpro Hldgs

Adicet Bio

Agenus

Adlai Nortye Ltd. - American Depositary Shares

Adlai Nortye

Annovis Bio

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Aerovate Therapeutics, Inc. - Common Stock

Aerovate Therapeutics

Avalo Therapeutics

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

BeyondSpring

Cibus

CytomX Therapeutics

FibroBiologics

Generation Bio

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

Mural Oncology

PMV Pharma

Quince Therapeutics

SELLAS Life Sciences Group, Inc. - Common Stock

SELLAS Life Sciences Gr

Unicycive Therapeutics, Inc. - Common Stock

Unicycive Therapeutics

Jones Trading

HC Wainwright & Co.

버서스 시스템즈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VS#NASDAQ">VS</a>)의 주가는 회사가 <a href="https://www.benzinga.com/quote/VS/news" target="_blank" rel="noopener" data-google-interstitial="false">국제적인 입지</a>를 성장시키기 위한 전략의 일환으로 회사가 브라질 시장으로의 확장을 발표한 후 급등했다.
버서스 시스템즈의 주가가 금요일 프리마켓 거래에서 71.2% 상승하여 $3.39에 거래되었다.
금요일 프리마켓 거래에서 움직임이 있는 다른 주식들도 있다.
<h3 class="wp-block-heading">상승 종목</h3>
<ul>
<li>아이스페시맨(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>)은 hMPV 바이오스펙리멘의 공급자를 확보했다고 발표한 후 프리마켓 거래에서 49.1% 상승하여 $4.25에 거래되었다.</li>
<li>누클레우스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>)는 나스닥 상장 폐지 통지를 해결하고 상장 기준을 준수하고 있다고 발표한 후 33% 상승하여 $27.30에 거래되었다.</li>
<li>사이닝 데이 스포츠(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGN#NYSE">SGN</a>)는 목요일에 9% 하락한 후 금요일 프리마켓 거래에서 19.2% 상승하여 $2.55에 거래되었다.</li>
<li>유클라우드링크 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>)는 WH 스미스 PLC의 인모션 엔터테인먼트 그룹(InMotion Entertainment Group)과 최근 협력 계약을 체결했다고 발표한 후 프리마켓 거래에서 18.7% 상승하여 $1.59에 거래되었다.</li>
<li>트레저 글로벌(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>)는 목요일에 약 7% 상승한 후 프리마켓 거래에서 15.3% 상승하여 $0.2471에 거래되었다.</li>
<li>TXNM 에너지(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXNM#NYSE">TXNM</a>)는 프리 마켓 거래에서 14.3% 상승하여 $55.99에 거래되었다.</li>
<li>트리스 메디컬 컨셉츠(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMCI#NASDAQ">TMCI</a>)는 2024년 4분기 및 전체 연도 매출에 대한 예비, 감사되지 않은 수치를 발표한 후 프리마켓 거래에서 14% 상승하여 $9.40에 거래되었다.</li>
<li>LSI 인더스트리즈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYTS#NASDAQ">LYTS</a>)는 2025 회계연도 2분기 실적을 2025년 1월 23일 목요일 시장 개장 전 발표할 것이라고 발표한 후 프리마켓 거래에서 8.8% 상승하여 $21.00에 거래되었다.</li>
<li>오소픽스 메디컬(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>)은 프리마켓 거래에서 8.1% 상승하여 $19.39에 거래되었다.</li>
</ul>
<h3 class="wp-block-heading">하락 종목</h3>
<ul>
<li>비즐리 브로드캐스트 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBGI#NASDAQ">BBGI</a>)은 프리마켓 거래에서 43.8% 하락하여 $5.00에 거래되었다.</li>
<li>비아비 솔루션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>)은 프리마켓 거래에서 19.3% 하락하여 $8.10에 거래되었다. 비아비 솔루션은 2025 회계연도 2분기 재무 실적을 2025년 1월 30일 목요일 시장 종료 후 발표할 것이다.</li>
<li>FOXO 테크놀로지스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>)는 목요일에 58% 상승한 후 금요일 프리마켓 거래에서 18.4% 하락하여 $0.2566에 거래되었다.</li>
<li>네이처스 선샤인 프로덕츠(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>)는 프리마켓 거래에서 15.9% 하락하여 $12.00에 거래되었다.</li>
<li>엘리시오 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>)는 프리마켓 거래에서 12.8% 하락하여 $5.61에 거래되었다.</li>
<li>G. 윌리푸드 인터내셔널(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WILC#NASDAQ">WILC</a>)는 프리마켓 거래에서 11.5% 하락하여 $14.01에 거래되었다.</li>
<li>바이카라 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAX#NASDAQ">BCAX</a>)는 목요일에 8% 하락한 후 금요일 프리마켓 거래에서 11.5% 하락하여 $10.51에 거래되었다.</li>
<li>J.B. 헌트 트랜스포트 서비스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>)는 회사가 목요일에 예상보다 낮은 4분기 실적을 발표한 후 프리마켓 거래에서 10.3% 하락하여 $167.00에 거래되었다.</li>
<li>MiMedx 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>)은 프리마켓 거래에서 6.3% 하락하여 $8.50에 거래되었다.</li>
<li>알보텍(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>)은 회사가 $500만 공모 가격을 발표한 후 프리마켓 거래에서 5% 하락하여 $12.60에 거래되었다.</li>
<li></li>
</ul>
이것도 읽어보세요:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EA%B8%88%EC%9A%94%EC%9D%BC-%EC%A3%BC%EB%AA%A9%ED%95%B4%EC%95%BC-%ED%95%A0-%EC%A3%BC%EC%8B%9D-%ED%8C%A8%EC%8A%A4%EB%84%90-jb-%ED%97%8C%ED%8A%B8-%EC%8A%A4%ED%85%8C%EC%9D%B4%ED%8A%B8-%EC%8A%A4/" target="_blank" rel="noopener">금요일 주목해야 할 주식: 패스널, JB 헌트, 스테이트 스트리트, 코보 및 슐럼버거</a></li>
</ul>
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Elicio Therapeutics

뉴스

에 대한 최신 뉴스 Elicio Therapeutics (NASDAQ:ELTX) 주식

금요일, 1월 17, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌